GlassScriptPhysician profile
Stanitia W Davis
NPI 1942463567
$1,528.48
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2020: $207 · 2021: $384 · 2022: $286 · 2023: $101 · 2024: $96.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $197.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $564.61 | 2019-2022 | |
| Horizon Therapeutics Plc | $285.29 | 2021-2023 | Krystexxa |
| Cardiovascular Systems INC. | $124.49 | 2019-2021 | |
| Convatec INC. | $123.09 | 2023-2024 | |
| Organogenesis INC. | $78.49 | 2020-2022 | |
| Misonix INC | $48.70 | 2020 | |
| Kerecis Limited | $36.07 | 2020 | |
| Nabriva Therapeutics, Plc | $32.27 | 2020 | |
| Acera Surgical, INC. | $31.57 | 2020 | |
| Alon Medical Technology | $28.93 | 2024 | |
| Integra Lifesciences Corporation | $27.00 | 2019 | |
| Paragon 28, INC. | $21.91 | 2019 | |
| Averitas Pharma INC. | $21.75 | 2024 | Qutenza |
| Astrazeneca Pharmaceuticals LP | $18.12 | 2020 | |
| Aroa Biosurgery Incorporated | $16.86 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hartmann USA, INC. | $16.48 | 2021 | |
| Melinta Therapeutics, LLC | $15.82 | 2019 | |
| Merck Sharp & Dohme LLC | $12.99 | 2019 | |
| Bsn Medical INC | $12.31 | 2019 | |
| Hollister Incorporated | $11.61 | 2021 | |
| Medline Industries LP | $0.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanitia Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.